Venus Remedies Secures Marketing Authorization in Philippines

Venus Remedies Limited is pleased to announce the grant of Marketing Authorization for Pemetrexed 500 mg, a chemotherapeutic agent widely used in the treatment of lung cancer and mesothelioma, in the Philippines. This authorization marks a significant milestone in the company's journey to strengthen its presence in the high-growth Southeast Asian pharmaceutical market.

Shares of Venus Remedies Limited was last trading in BSE at Rs. 323.15 as compared to the previous close of Rs. 326.90. The total number of shares traded during the day was 1274 in over 172 trades.

The stock hit an intraday high of Rs. 343.00 and intraday low of 321.00. The net turnover during the day was Rs. 412522.00.

Source : Equity Bulls

Keywords

VenusRemedies INE411B01019 MarketingAuthorization Philippines